Guido Davidzon | Profiles RNS

Guido Davidzon, MD

Clinical Assistant Professor

Boston University Chobanian & Avedisian School of Medicine

Radiology

MD, Universidad Maimónides
MS, Massachusetts Institute of Technology

Websites

	Stanford University Faculty
	LinkedIn
	BUMC
	Google Scholar
	Research Gate

ORCID : 0000-0001-5579-6825

Dr. Guido A. Davidzon is a physician-scientist board certified in Nuclear Medicine. He graduated with honors from medical school in Argentina and completed an internship at Yale University New-Haven Hospital in Connecticut. He did his residency and was chief resident at Stanford Health Care. He completed a research fellowship in mitochondrial diseases at Columbia University in New York and, a U.S. National Library of Medicine Award supported, Biomedical Informatics fellowship at Massachusetts General Hospital in conjunction with a Science Masters at MIT.

Dr. Davidzon is Clinical Assistant Professor in the Department of Radiology at Stanford University and Chobanian and Avedisian School of Medicine. His clinical specialties include early diagnostic imaging of cancer, coronary artery disease, and dementias using molecular probes as well as the treatment of cancer for which he employs targeted radiopharmaceutical therapy.

Dr. Davidzon investigates the use of machine learning in medical imaging to improve clinical outcomes, he is involved in the professional Society of Nuclear Medicine and Molecular Imaging. He serves as a peer reviewer for multiple medical journals. Dr. Davidzon is a native of Buenos Aires, Argentina and has lived in the U.S. for over a decade. He travels to Argentina frequently, with his wife and three sons.

Kaiser Permanente Santa Clara Medical Center

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Song H, Ferri V, Duan H, Aparici CM, Davidzon G, Franc BL, Moradi F, Nguyen J, Shah J, Iagaru A. SPECT at the speed of PET: a feasibility study of CZT-based whole-body SPECT/CT in the post 177Lu-DOTATATE and 177Lu-PSMA617 setting. Eur J Nucl Med Mol Imaging. 2023 Mar 04. PMID: 36869177

Duan H, Ghanouni P, Daniel B, Rosenberg J, Thong A, Kunder C, Mari Aparici C, Davidzon GA, Moradi F, Sonn GA, Iagaru A. A Pilot Study of 68Ga-PSMA11 and 68Ga-RM2 PET/MRI for Biopsy Guidance in Patients with Suspected Prostate Cancer. J Nucl Med. 2022 Nov 17. PMID: 36396456

Wilson EN, Young CB, Ramos Benitez J, Swarovski MS, Feinstein I, Vandijck M, Le Guen Y, Kasireddy NM, Shahid M, Corso NK, Wang Q, Kennedy G, Trelle AN, Lind B, Channappa D, Belnap M, Ramirez V, Skylar-Scott I, Younes K, Yutsis MV, Le Bastard N, Quinn JF, van Dyck CH, Nairn A, Fredericks CA, Tian L, Kerchner GA, Montine TJ, Sha SJ, Davidzon G, Henderson VW, Longo FM, Greicius MD, Wagner AD, Wyss-Coray T, Poston KL, Mormino EC, Andreasson KI. Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer's disease. Alzheimers Res Ther. 2022 Nov 12; 14(1):172. PMID: 36371232; PMCID: PMC9652927; DOI: 10.1186/s13195-022-01116-2;

Duan H, Ghanouni P, Daniel B, Rosenberg J, Davidzon GA, Mari Aparici C, Kunder C, Sonn G, Iagaru A. A Pilot Study of 68Ga-PSMA11 and 68Ga-RM2 PET/MRI for Evaluation of Prostate Cancer Response to High Intensity Focused Ultrasound (HIFU) Therapy. J Nucl Med. 2022 Nov 03. PMID: 36328488

Duan H, Ferri V, Fisher GA, Shaheen S, Davidzon GA, Iagaru A, Mari Aparici C. Evaluation of Liver and Renal Toxicity in Peptide Receptor Radionuclide Therapy for Somatostatin Receptor Expressing Tumors: A 2-Year Follow-Up. Oncologist. 2022 Jun 08; 27(6):447-452. PMID: 35641196; PMCID: PMC9177120; DOI: 10.1093/oncolo/oyab072;

Duan H, Baratto L, Fan RE, Soerensen SJC, Liang T, Chung BI, Thong AEC, Gill H, Kunder C, Stoyanova T, Rusu M, Loening AM, Ghanouni P, Davidzon GA, Moradi F, Sonn GA, Iagaru A. Correlation of 68Ga-RM2 PET with Postsurgery Histopathology Findings in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Cancer. J Nucl Med. 2022 Dec; 63(12):1829-1835. PMID: 35552245

Moradi F, Duan H, Song H, Davidzon GA, Chung BI, Thong AEC, Loening AM, Ghanouni P, Sonn G, Iagaru A. 68Ga-PSMA-11 PET/MRI in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Adenocarcinoma: PET Findings Correlate with Outcomes After Definitive Treatment. J Nucl Med. 2022 Dec; 63(12):1822-1828. PMID: 35512996

Napolioni V, Fredericks CA, Kim Y, Channappa D, Khan RR, Kim LH, Zafar F, Couthouis J, Davidzon GA, Mormino EC, Gitler AD, Montine TJ, Schüle B, Greicius MD. Phenotypic Heterogeneity among GBA p.R202X Carriers in Lewy Body Spectrum Disorders. Biomedicines. 2022 Jan 12; 10(1). PMID: 35052839; PMCID: PMC8774039; DOI: 10.3390/biomedicines10010160;

Hall JN, Mormino E, Ng A, Boumis A, Gaudioso JL, Davidzon GA, Sha SJ. Six Recurrent Amyloid-Related Imaging Abnormality Episodes in a Patient Treated With Aducanumab. JAMA Neurol. 2022 01 01; 79(1):87-89. PMID: 34747986; PMCID: PMC9677548; DOI: 10.1001/jamaneurol.2021.3933;

Duan H, Baratto L, Hatami N, Liang T, Mari Aparici C, Davidzon GA, Iagaru A. 68Ga-PSMA11 PET/CT for biochemically recurrent prostate cancer: Influence of dual-time and PMT- vs SiPM-based detectors. Transl Oncol. 2022 Jan; 15(1):101293. PMID: 34823095; PMCID: PMC8626686; DOI: 10.1016/j.tranon.2021.101293;

Showing 10 of 65 results. Show More

Chaudhari AS, Mittra E, Davidzon GA, Gulaka P, Gandhi H, Brown A, Zhang T, Srinivas S, Gong E, Zaharchuk G, Jadvar H. Author Correction: Low-count whole-body PET with deep learning in a multicenter and externally validated study. NPJ Digit Med. 2021 Sep 14; 4(1):139. PMID: 34521985; PMCID: PMC8440668; DOI: 10.1038/s41746-021-00512-6;

Beinat C, Patel CB, Haywood T, Murty S, Naya L, Castillo JB, Reyes ST, Phillips M, Buccino P, Shen B, Park JH, Koran MEI, Alam IS, James ML, Holley D, Halbert K, Gandhi H, He JQ, Granucci M, Johnson E, Liu DD, Uchida N, Sinha R, Chu P, Born DE, Warnock GI, Weissman I, Hayden-Gephart M, Khalighi M, Massoud TF, Iagaru A, Davidzon G, Thomas R, Nagpal S, Recht LD, Gambhir SS. A Clinical PET Imaging Tracer ([18F]DASA-23) to Monitor Pyruvate Kinase M2-Induced Glycolytic Reprogramming in Glioblastoma. Clin Cancer Res. 2021 12 01; 27(23):6467-6478. PMID: 34475101; PMCID: PMC8639752; DOI: 10.1158/1078-0432.CCR-21-0544;

Chaudhari AS, Mittra E, Davidzon GA, Gulaka P, Gandhi H, Brown A, Zhang T, Srinivas S, Gong E, Zaharchuk G, Jadvar H. Low-count whole-body PET with deep learning in a multicenter and externally validated study. NPJ Digit Med. 2021 Aug 23; 4(1):127. PMID: 34426629; PMCID: PMC8382711; DOI: 10.1038/s41746-021-00497-2;

Baratto L, Toriihara A, Hatami N, Aparici CM, Davidzon G, Levin CS, Iagaru A. Results of a Prospective Trial to Compare 68Ga-DOTA-TATE with SiPM-Based PET/CT vs. Conventional PET/CT in Patients with Neuroendocrine Tumors. Diagnostics (Basel). 2021 May 30; 11(6). PMID: 34070751; PMCID: PMC8228776; DOI: 10.3390/diagnostics11060992;

Fite BZ, Hinostroza V, States L, Hicks-Nelson A, Baratto L, Kallianos K, Codari M, Yu B, Jha P, Shams M, Stoyanova T, Chapelin FF, Liu A, Rashidi A, Soto F, Quintana Y, Davidzon GA, Marycz K, Gibbs IC, Chonde DB, Patel CB, Daldrup-Link HE. Increasing Diversity in Radiology and Molecular Imaging: Current Challenges. Mol Imaging Biol. 2021 10; 23(5):625-638. PMID: 33903986; PMCID: PMC8074707; DOI: 10.1007/s11307-021-01610-3;

Eyuboglu S, Angus G, Patel BN, Pareek A, Davidzon G, Long J, Dunnmon J, Lungren MP. Multi-task weak supervision enables anatomically-resolved abnormality detection in whole-body FDG-PET/CT. Nat Commun. 2021 03 25; 12(1):1880. PMID: 33767174; PMCID: PMC7994797; DOI: 10.1038/s41467-021-22018-1;

Baratto L, Song H, Duan H, Hatami N, Bagshaw HP, Buyyounouski M, Hancock S, Shah S, Srinivas S, Swift P, Moradi F, Davidzon G, Iagaru A. PSMA- and GRPR-Targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate Cancer. J Nucl Med. 2021 11; 62(11):1545-1549. PMID: 33674398; PMCID: PMC8612333; DOI: 10.2967/jnumed.120.259630;

Nakamoto R, Zaba LC, Liang T, Reddy SA, Davidzon G, Aparici CM, Nguyen J, Moradi F, Iagaru A, Franc BL. Prognostic Value of Bone Marrow Metabolism on Pretreatment 18F-FDG PET/CT in Patients with Metastatic Melanoma Treated with Anti-PD-1 Therapy. J Nucl Med. 2021 10; 62(10):1380-1383. PMID: 33547210; DOI: 10.2967/jnumed.120.254482;

Nakamoto R, Harrison C, Song H, Guja KE, Hatami N, Nguyen J, Moradi F, Franc BL, Aparici CM, Davidzon G, Iagaru A. The Clinical Utility of 18F-Fluciclovine PET/CT in Biochemically Recurrent Prostate Cancer: an Academic Center Experience Post FDA Approval. Mol Imaging Biol. 2021 08; 23(4):614-623. PMID: 33469884; DOI: 10.1007/s11307-021-01583-3;

Chen KT, Toueg TN, Koran MEI, Davidzon G, Zeineh M, Holley D, Gandhi H, Halbert K, Boumis A, Kennedy G, Mormino E, Khalighi M, Zaharchuk G. True ultra-low-dose amyloid PET/MRI enhanced with deep learning for clinical interpretation. Eur J Nucl Med Mol Imaging. 2021 07; 48(8):2416-2425. PMID: 33416955; PMCID: PMC8891344; DOI: 10.1007/s00259-020-05151-9;

Trelle AN, Carr VA, Wilson EN, Swarovski MS, Hunt MP, Toueg TN, Tran TT, Channappa D, Corso NK, Thieu MK, Jayakumar M, Nadiadwala A, Guo W, Tanner NJ, Bernstein JD, Litovsky CP, Guerin SA, Khazenzon AM, Harrison MB, Rutt BK, Deutsch GK, Chin FT, Davidzon GA, Hall JN, Sha SJ, Fredericks CA, Andreasson KI, Kerchner GA, Wagner AD, Mormino EC. Association of CSF Biomarkers With Hippocampal-Dependent Memory in Preclinical Alzheimer Disease. Neurology. 2021 03 09; 96(10):e1470-e1481. PMID: 33408146; PMCID: PMC8055319; DOI: 10.1212/WNL.0000000000011477;

Zaharchuk G, Davidzon G. Artificial Intelligence for Optimization and Interpretation of PET/CT and PET/MR Images. Semin Nucl Med. 2021 03; 51(2):134-142. PMID: 33509370; DOI: 10.1053/j.semnuclmed.2020.10.001;

Davidzon G, Franc B, Mari Aparici C, Moradi F, Nguyen J, Iagaru A. Obituary for Sanjiv Sam Gambhir, MD, PhD. Clin Nucl Med. 2020 11; 45(11):933. PMID: 32956118; DOI: 10.1097/RLU.0000000000003284;

Guja KE, Brown R, Girod B, Song H, Harrison C, Franc BL, Moradi F, Davidzon G, Iagaru A, Aparici CM. An unusual presentation of recurrent T cell lymphoma: angiocentric pattern of cutaneous uptake on [18F]FDG PET/CT. Eur J Nucl Med Mol Imaging. 2021 04; 48(4):1256-1257. PMID: 32918110; DOI: 10.1007/s00259-020-05026-z;

Nakamoto R, C Zaba L, Rosenberg J, Arani Reddy S, W Nobashi T, Ferri V, Davidzon G, Mari Aparici C, Nguyen J, Moradi F, Iagaru A, Lewis Franc B. Imaging Characteristics and Diagnostic Performance of 2-deoxy-2-[18F]fluoro-D-Glucose PET/CT for Melanoma Patients Who Demonstrate Hyperprogressive Disease When Treated with Immunotherapy. Mol Imaging Biol. 2021 02; 23(1):139-147. PMID: 32789649; DOI: 10.1007/s11307-020-01526-4;

Mormino EC, Toueg TN, Azevedo C, Castillo JB, Guo W, Nadiadwala A, Corso NK, Hall JN, Fan A, Trelle AN, Harrison MB, Hunt MP, Sha SJ, Deutsch G, James M, Fredericks CA, Koran ME, Zeineh M, Poston K, Greicius MD, Khalighi M, Davidzon GA, Shen B, Zaharchuk G, Wagner AD, Chin FT. Tau PET imaging with 18F-PI-2620 in aging and neurodegenerative diseases. Eur J Nucl Med Mol Imaging. 2021 07; 48(7):2233-2244. PMID: 32572562; PMCID: PMC7755737; DOI: 10.1007/s00259-020-04923-7;

Lee JJ, Yang H, Franc BL, Iagaru A, Davidzon GA. Deep learning detection of prostate cancer recurrence with 18F-FACBC (fluciclovine, Axumin®) positron emission tomography. Eur J Nucl Med Mol Imaging. 2020 12; 47(13):2992-2997. PMID: 32556481; DOI: 10.1007/s00259-020-04912-w;

Chen KT, Schürer M, Ouyang J, Koran MEI, Davidzon G, Mormino E, Tiepolt S, Hoffmann KT, Sabri O, Zaharchuk G, Barthel H. Generalization of deep learning models for ultra-low-count amyloid PET/MRI using transfer learning. Eur J Nucl Med Mol Imaging. 2020 12; 47(13):2998-3007. PMID: 32535655; PMCID: PMC7680289; DOI: 10.1007/s00259-020-04897-6;

Reith F, Koran ME, Davidzon G, Zaharchuk G. Application of Deep Learning to Predict Standardized Uptake Value Ratio and Amyloid Status on 18F-Florbetapir PET Using ADNI Data. AJNR Am J Neuroradiol. 2020 06; 41(6):980-986. PMID: 32499247; PMCID: PMC7342760; DOI: 10.3174/ajnr.A6573;

Nakamoto R, Zaba LC, Rosenberg J, Reddy SA, Nobashi TW, Davidzon G, Aparici CM, Nguyen J, Moradi F, Iagaru A, Franc BL. Prognostic value of volumetric PET parameters at early response evaluation in melanoma patients treated with immunotherapy. Eur J Nucl Med Mol Imaging. 2020 11; 47(12):2787-2795. PMID: 32296882; DOI: 10.1007/s00259-020-04792-0;

Nobashi T, Zacharias C, Ellis JK, Ferri V, Koran ME, Franc BL, Iagaru A, Davidzon GA. Performance Comparison of Individual and Ensemble CNN Models for the Classification of Brain 18F-FDG-PET Scans. J Digit Imaging. 2020 04; 33(2):447-455. PMID: 31659587; PMCID: PMC7165199; DOI: 10.1007/s10278-019-00289-x;

Beinat C, Patel CB, Haywood T, Shen B, Naya L, Gandhi H, Holley D, Khalighi M, Iagaru A, Davidzon G, Gambhir SS. Human biodistribution and radiation dosimetry of [18F]DASA-23, a PET probe targeting pyruvate kinase M2. Eur J Nucl Med Mol Imaging. 2020 08; 47(9):2123-2130. PMID: 31938892; DOI: 10.1007/s00259-020-04687-0;

Girod BJ, Guja KE, Davidzon G, Chan F, Zucker E, Franc BL, Moradi F, Iagaru A, Aparici CM. Fungal endocarditis resembling primary cardiac malignancy in a patient with B-cell ALL with culture confirmation. Radiol Case Rep. 2020 Feb; 15(2):117-119. PMID: 31768196; PMCID: PMC6872837; DOI: 10.1016/j.radcr.2019.10.022;

Park SY, Barrato L, Hatami N, Davidzon G, Gambhir SS, Iagaru A. Initial experience with a PET/computed tomography system using silicon photomultiplier detectors. Nucl Med Commun. 2019 Nov; 40(11):1174-1178. PMID: 31568189; DOI: 10.1097/MNM.0000000000001088;

Song H, Harrison C, Duan H, Guja K, Hatami N, Franc BL, Moradi F, Aparici CM, Davidzon GA, Iagaru A. Prospective Evaluation of 18F-DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer in an Academic Center: A Focus on Disease Localization and Changes in Management. J Nucl Med. 2020 04; 61(4):546-551. PMID: 31628216; DOI: 10.2967/jnumed.119.231654;

Toriihara A, Nobashi T, Baratto L, Duan H, Moradi F, Park S, Hatami N, Aparici CM, Davidzon G, Iagaru A. Comparison of 3 Interpretation Criteria for 68Ga-PSMA11 PET Based on Inter- and Intrareader Agreement. J Nucl Med. 2020 04; 61(4):533-539. PMID: 31562226; DOI: 10.2967/jnumed.119.232504;

Mattonen SA, Davidzon GA, Benson J, Leung ANC, Vasanawala M, Horng G, Shrager JB, Napel S, Nair VS. Bone Marrow and Tumor Radiomics at 18F-FDG PET/CT: Impact on Outcome Prediction in Non-Small Cell Lung Cancer. Radiology. 2019 11; 293(2):451-459. PMID: 31526257; PMCID: PMC6822770; DOI: 10.1148/radiol.2019190357;

Toriihara A, Baratto L, Nobashi T, Park S, Hatami N, Davidzon G, Kunz PL, Iagaru A. Prognostic value of somatostatin receptor expressing tumor volume calculated from 68Ga-DOTATATE PET/CT in patients with well-differentiated neuroendocrine tumors. Eur J Nucl Med Mol Imaging. 2019 Oct; 46(11):2244-2251. PMID: 31350603; DOI: 10.1007/s00259-019-04455-9;

Laudicella R, Davidzon G, Vasanawala S, Baldari S, Iagaru A. 18F-FDG PET/MR Refines Evaluation in Newly Diagnosed Metastatic Urethral Adenocarcinoma. Nucl Med Mol Imaging. 2019 Aug; 53(4):296-299. PMID: 31456863; PMCID: PMC6694445; DOI: 10.1007/s13139-019-00597-8;

Mattonen SA, Davidzon GA, Bakr S, Echegaray S, Leung ANC, Vasanawala M, Horng G, Napel S, Nair VS. [18F] FDG Positron Emission Tomography (PET) Tumor and Penumbra Imaging Features Predict Recurrence in Non-Small Cell Lung Cancer. Tomography. 2019 03; 5(1):145-153. PMID: 30854452; PMCID: PMC6403030; DOI: 10.18383/j.tom.2018.00026;

Bradley KM, McGowan DR, Gleeson FV, Johnson GB, Young JR, Levin CS, Davidzon GA, Iagaru AH. Embrace Progress. J Nucl Med. 2018 07; 59(7):1169. PMID: 29700130; DOI: 10.2967/jnumed.118.212761;

Sonni I, Baratto L, Park S, Hatami N, Srinivas S, Davidzon G, Gambhir SS, Iagaru A. Initial experience with a SiPM-based PET/CT scanner: influence of acquisition time on image quality. EJNMMI Phys. 2018 Apr 18; 5(1):9. PMID: 29666972; PMCID: PMC5904089; DOI: 10.1186/s40658-018-0207-x;

Baratto L, Davidzon GA, Moghbel M, Hatami N, Iagaru A, Mittra ES. Comparison Between Different PET and CT-Based Imaging Interpretation Criteria at Interim Imaging in Patients With Diffuse Large B-Cell Lymphoma. Clin Nucl Med. 2018 Jan; 43(1):1-8. PMID: 29076913

Baratto L, Park SY, Hatami N, Davidzon G, Srinivas S, Gambhir SS, Iagaru A. 18F-FDG silicon photomultiplier PET/CT: A pilot study comparing semi-quantitative measurements with standard PET/CT. PLoS One. 2017; 12(6):e0178936. PMID: 28582472; PMCID: PMC5459477; DOI: 10.1371/journal.pone.0178936;

Celi LA, Davidzon G, Johnson AE, Komorowski M, Marshall DC, Nair SS, Phillips CT, Pollard TJ, Raffa JD, Salciccioli JD, Salgueiro FM, Stone DJ. Bridging the Health Data Divide. J Med Internet Res. 2016 Dec 20; 18(12):e325. PMID: 27998877; PMCID: PMC5209608; DOI: 10.2196/jmir.6400;

Mittra ES, Davidzon G. Case 207: Hodgkin lymphoma with paraneoplastic hypercalcemic pancreatitis. Radiology. 2014 Jul; 272(1):296-300. PMID: 24956051

Nair VS, Gevaert O, Davidzon G, Plevritis SK, West R. NF-?B protein expression associates with (18)F-FDG PET tumor uptake in non-small cell lung cancer: a radiogenomics validation study to understand tumor metabolism. Lung Cancer. 2014 Feb; 83(2):189-96. PMID: 24355259; PMCID: PMC3922123; DOI: 10.1016/j.lungcan.2013.11.001;

Celi LA, Galvin S, Davidzon G, Lee J, Scott D, Mark R. A Database-driven Decision Support System: Customized Mortality Prediction. J Pers Med. 2012 Sep 27; 2(4):138-48. PMID: 23766893; PMCID: PMC3678286; DOI: 10.3390/jpm2040138;

Mosci C, Davidzon GA, Quon A. FDG-PET/CT Initial and Subsequent Therapy Evaluation: Progressing to PET/MR Imaging. PET Clin. 2012 Oct; 7(4):369-80. PMID: 27157644

Nair VS, Gevaert O, Davidzon G, Napel S, Graves EE, Hoang CD, Shrager JB, Quon A, Rubin DL, Plevritis SK. Prognostic PET 18F-FDG uptake imaging features are associated with major oncogenomic alterations in patients with resected non-small cell lung cancer. Cancer Res. 2012 Aug 01; 72(15):3725-34. PMID: 22710433; PMCID: PMC3596510; DOI: 10.1158/0008-5472.CAN-11-3943;

Celi LA, Tang RJ, Villarroel MC, Davidzon GA, Lester WT, Chueh HC. A Clinical Database-Driven Approach to Decision Support: Predicting Mortality Among Patients with Acute Kidney Injury. J Healthc Eng. 2011 Mar; 2(1):97-110. PMID: 22844575; PMCID: PMC3404157; DOI: 10.1260/2040-2295.2.1.97;

Akman HO, Davidzon G, Tanji K, Macdermott EJ, Larsen L, Davidson MM, Haller RG, Szczepaniak LS, Lehman TJ, Hirano M, DiMauro S. Neutral lipid storage disease with subclinical myopathy due to a retrotransposal insertion in the PNPLA2 gene. Neuromuscul Disord. 2010 Jun; 20(6):397-402. PMID: 20471263; PMCID: PMC7546172; DOI: 10.1016/j.nmd.2010.04.004;

Rohrbach M, Chitayat D, Maegawa G, Shanske S, Davidzon G, Chong K, Clarke JT, Toi A, Tarnopolsky M, Robinson B, Blaser S. Intracerebral periventricular pseudocysts in a fetus with mitochondrial depletion syndrome: an association or coincidence. Fetal Diagn Ther. 2009; 25(2):177-82. PMID: 19321960

Davidzon G, Pankey E, Loudon T, Schmid P, Berger B, Berkowicz D. SemanticDx: a prototype to facilitate use of biostatistics at the point-of-care. AMIA Annu Symp Proc. 2008 Nov 06; 921. PMID: 18999188

Ferraris S, Clark S, Garelli E, Davidzon G, Moore SA, Kardon RH, Bienstock RJ, Longley MJ, Mancuso M, Gutiérrez Ríos P, Hirano M, Copeland WC, DiMauro S. Progressive external ophthalmoplegia and vision and hearing loss in a patient with mutations in POLG2 and OPA1. Arch Neurol. 2008 Jan; 65(1):125-31. PMID: 18195150; PMCID: PMC2364721; DOI: 10.1001/archneurol.2007.9;

Wiltshire E, Davidzon G, DiMauro S, Akman HO, Sadleir L, Haas L, Zuccollo J, McEwen A, Thorburn DR. Juvenile Alpers disease. Arch Neurol. 2008 Jan; 65(1):121-4. PMID: 18195149

Mancuso M, Ricci G, Choub A, Filosto M, DiMauro S, Davidzon G, Tessa A, Santorelli FM, Murri L, Siciliano G. Autosomal dominant psychiatric disorders and mitochondrial DNA multiple deletions: report of a family. J Affect Disord. 2008 Feb; 106(1-2):173-7. PMID: 17588675

Hakonen AH, Davidzon G, Salemi R, Bindoff LA, Van Goethem G, Dimauro S, Thorburn DR, Suomalainen A. Abundance of the POLG disease mutations in Europe, Australia, New Zealand, and the United States explained by single ancient European founders. Eur J Hum Genet. 2007 Jul; 15(7):779-83. PMID: 17426723

Scuderi C, Borgione E, Musumeci S, Elia M, Castello F, Fichera M, Davidzon G, DiMauro S. Severe encephalomyopathy in a patient with homoplasmic A5814G point mutation in mitochondrial tRNACys gene. Neuromuscul Disord. 2007 Mar; 17(3):258-61. PMID: 17241783

Oskoui M, Davidzon G, Pascual J, Erazo R, Gurgel-Giannetti J, Krishna S, Bonilla E, De Vivo DC, Shanske S, DiMauro S. Clinical spectrum of mitochondrial DNA depletion due to mutations in the thymidine kinase 2 gene. Arch Neurol. 2006 Aug; 63(8):1122-6. PMID: 16908738

DiMauro S, Davidzon G, Hirano M. A polymorphic polymerase. Brain. 2006 Jul; 129(Pt 7):1637-9. PMID: 16803839

Davidzon G, Greene P, Mancuso M, Klos KJ, Ahlskog JE, Hirano M, DiMauro S. Early-onset familial parkinsonism due to POLG mutations. Ann Neurol. 2006 May; 59(5):859-62. PMID: 16634032

Davidzon G, Mancuso M, Ferraris S, Quinzii C, Hirano M, Peters HL, Kirby D, Thorburn DR, DiMauro S. POLG mutations and Alpers syndrome. Ann Neurol. 2005 Jun; 57(6):921-3. PMID: 15929042

Mancuso M, Davidzon G, Kurlan RM, Tawil R, Bonilla E, Di Mauro S, Powers JM. Hereditary ferritinopathy: a novel mutation, its cellular pathology, and pathogenetic insights. J Neuropathol Exp Neurol. 2005 Apr; 64(4):280-94. PMID: 15835264

Dimauro S, Davidzon G. Mitochondrial DNA and disease. Ann Med. 2005; 37(3):222-32. PMID: 16019721

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 65 publications over 18 distinct years, with a maximum of 12 publications in 2021

Bar chart showing 65 publications over 18 distinct years, with a maximum of 12 publications in 2021

Year	Publications
2005	3
2006	3
2007	3
2008	3
2009	1
2010	1
2011	1
2012	3
2013	1
2014	1
2016	1
2017	1
2018	3
2019	8
2020	11
2021	12
2022	8
2023	1

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Nuclear Medicine
Molecular Imaging
Positron Emission Tomography
Targeted Radionuclide Therapy

Contact for Mentoring:

820 Harrison Ave
Boston MA 02118
Google Map

617.638.6610

Download vCard

Davidzon's Networks

Click the "See All" links for more information and interactive visualizations

Concepts

See all (259) concept(s)

Similar People

See all (60) people

Same Department

Search Department